John W. Lindsey

Dr. John W. Lindsey is a Professor in the Department of Neurology at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). He serves as the Director of the Division of Multiple Sclerosis and Neuroimmunology, where he maintains a busy clinical practice specializing in immune and inflammatory diseases of the brain and spinal cord.

Dr. Lindsey's educational background includes:

• Medical School: Harvard University, Cambridge, MA
• Residency in Neurology: Stanford University Medical Center, Stanford, CA
• Neuro Immunology Fellowship: Stanford University Medical Center, Stanford, CA

His research interests focus on multiple sclerosis and neuroimmunology, with specific emphasis on:

• The cause of MS and its relationship with Epstein-Barr virus
• Clinical research on new treatments for MS and neuromyelitis optica
• Autoimmune or immune-mediated neurologic diseases including neuromyelitis optica, sarcoid, and vasculitis

Dr. Lindsey is actively involved in both clinical trials and laboratory research to advance understanding and treatment of these conditions.

Dr. Lindsey is a member of the American Academy of Neurology and the American Association of Immunologists, reflecting his dual expertise in neurology and immunology. His recent publications (2019-2024) demonstrate a strong focus on understanding MS pathogenesis, developing new treatments, and exploring connections between the immune system, gut microbiome, and neurological disorders.

As principal investigator, Dr. Lindsey leads multiple clinical studies of new treatments for multiple sclerosis and neuromyelitis optica. His laboratory research program investigates the cause of multiple sclerosis and its relation to infection with Epstein-Barr virus. His work spans from basic science investigations to clinical applications, with recent publications covering topics such as trigeminal neuralgia in MS, novel treatment approaches, and the role of gut microbiota in autoimmune diseases.